— Know what they know.
Not Investment Advice

CHME OTC

China Medicine Corp.
1W: -21.3% 1M: -52.1% 3M: +51.2% YTD: -4.6% 1Y: +2483.3% 3Y: +30900.0% 5Y: +55.0%
$0.03
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Pharmaceuticals · Tech Score Sell · Power 44 · $735074 mcap · 15M float · 0.026% daily turnover · Short 99% of daily vol
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.7M
52W Range0.0012-0.0688
Volume5,000
Avg Volume4,037
Beta-8.66
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOSenshan Yang
Employees281
SectorHealthcare
IndustryMedical - Pharmaceuticals
IPO Date2006-11-30
Websitecmc621.com
2/F, Guangri Tower
Guangzhou, GD 510006
CN
86 20 8739 1718
About China Medicine Corp.

China Medicine Corporation produces and distributes prescription and over the counter drugs, traditional Chinese medicine products, herbs and dietary-supplements, medical devices, and medical formulations in China. The company offers various products for applications, including oncology, high blood pressure, and removal of toxins from food and animal feeds. It provides products that treat stagnation of the heart blood, obstruction of qi in the chest, cardiodynia, headache, and dysmenorrhea; upper respiratory tract infection, acute faucitis, acute tonsillitis, acute gastroenteritis, etc.; acute and chronic hepatitis, deferment hepatitis, cholecystitis, etc.; irregular menstruation, dysmenorrhea, and amenorrhea; anemia and deficiency of vital energy; palpitation, dizziness, and fatigue; and cerebral arteriosclerosis and ischemic stroke. The company distributes its products through a sales network in China. The company was formerly known as Lounsberry Holdings III, Inc. and changed its name to China Medicine Corporation in May 2006. China Medicine Corporation was founded in 2005 and is based in Guangzhou, China.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms